SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-21-000104
Filing Date
2021-09-15
Accepted
2021-09-15 08:15:44
Documents
18
Period of Report
2021-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20210914.htm   iXBRL 8-K 53573
2 EX-10.1 alpn-ex101_8xkx2021pipe.htm EX-10.1 736691
3 EX-10.2 alpn-ex102_8xkx2021pipe.htm EX-10.2 352467
4 EX-10.3 alpn-ex103_8xkx2021pipe.htm EX-10.3 109370
5 EX-10.4 alpn-ex104_8xkx2021pipe.htm EX-10.4 40060
6 EX-99.1 ex991alpn-pr2021pipe.htm EX-99.1 15010
10 image_0a.jpg GRAPHIC 161
  Complete submission text file 0001626199-21-000104.txt   1631264

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20210914.xsd EX-101.SCH 1951
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20210914_lab.xml EX-101.LAB 24849
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20210914_pre.xml EX-101.PRE 13082
11 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20210914_htm.xml XML 11253
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 211254315
SIC: 2834 Pharmaceutical Preparations